The secretion of this cytokine is important for CSC survival [179] and necessary to induce the CD44+/CD24 low phenotype in breast cancer cell lines, thus confirming that the IL-6-JAK2-STAT3 pathway may have a key role in the conversion of non-CSCs into CSCs. The gene discussed is STAT3; the disease is breast carcinoma.